Luminex, EMD Millipore Extend Distribution Agreement | GenomeWeb

NEW YORK (GenomeWeb News) – Luminex said after the close of the market on Tuesday it has extended its global supply and distribution agreement with EMD Millipore.

The deal with EMD Millipore, the Life Science division of Merck KGaA, is anticipated to further the development of protein assays by EMD Millipore for Luminex's xMAP platform, the Austin, Texas-based firm said. EMD Millipore also will continue to offer all of Luminex's xMAP systems, including the Magpix, Luminex 100/200, and Flexmap 3D.

Financial and other terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.